TrialInflammopharmacology2025

Boswellic acids as an adjunct therapy in Parkinson's disease: a double-blind clinical trial investigating on its effects on motor symptoms and inflammatory markers.

Somayyeh Shateri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.